Коронарная ангиопластика у потенциальных реципиентов донорского сердца
Диссертация
Пациентов с выраженным и распространенным рубцовым поражением миокарда много и количество «перспективного» в плане функционального восстановления миокарда у таких пациентов зачастую незначимо. Вопрос возможности реваскуляризации для данной категории больных (без значимого количества дисфункционального, но потенциально жизнеспособного миокарда) практически ни кем не обсуждался, т.к. эти пациенты… Читать ещё >
Список литературы
- Гуреев C.B. Аортокоронарное шунтирование и трансплантация аутологичных стволовых клеток костного мозга в лечении ишемической сердечной недостаточности. 2004. Диссертация на соискание ученой степени доктор медицинских наук.
- Поляков P.C. Коронарная ангиопластика у больных ИБС с низкой фракцией выброса левого желудочка- диссертация на соискание ученой степени кандидата медицинских наук. Москва 2005.
- Никитин Н.П. Аляви A.J1. Особенности диастол и ческой дисфункции в процессе ремоделирования левого желудочка сердца при хронической сердечной недостаточности // Кардиология 1998: 3: 56 -61.
- Жаров Е. И. Зиц С. В. Значение спектральной допплер-эхокардиографии в диагностике и оценке тяжести синдрома застойной сердечной недостаточности. Кардиология 1996: 1: 47−50.
- Беленков Ю.Н. Роль нарушений систолы и диастолы в развитии сердечной недостаточности. Тер. арх. 1994: 9: 3−7.
- Агеев Ф. Т. Мареев В.Ю. Лопатин Ю. М. Беленков Ю.Н. Роль различных клинических, гемодинамических и нейрогуморальных факторов в определении тяжести хронической сердечной недостаточности. Кардиология 1995- 11:4−12.
- Carrel A. «On the experimental surgery of the thoracic aorta and the heart» Ann Surg. 1910−25−83−95.
- Beck C.S. «Principles underlying the operative approach to the treatment of myocardial ischemia» Ann Surg. 1943:118:788−806.
- Vienberg A.M."Development of anastomosis between coronary vessels and transplanted internal mammary artery" Can Med Assoc J: 1946−55:117−119.
- Favaloro R.G., Effler D.B. Groves L.K. et al, «Combined simultaneous procedures in the surgical treatment of the coronary artery disease» Ann Thorac Surg 1969−8:20−29.
- Jones E.L. Weintraub W.S. Craver J.M., Guyton R.A. Cohen C.L. «Coronary bypass surgery: is the operation different today?» J. Thorac. Cardiovasc. Surg. 1991. vl01. 108−115.
- Burch G.E. Gills T.D. Colcough H.L., «Ishemic Cardiomyopathy.» Am. heart J. 1970, Vol.79, pp. 291−292.
- Pautley G.A., Bristow J.D. «Ishemic cardiomyopathy.» Progr.Card.Desease, 1985. Vol.27, N2, pp. 95−114.
- Raftery E.B. Banks D.C. Oram S. Occlusive disease of the coronary arteries presenting as primary congestive cardiomyopathy. Lancet 1969- 2:1146−50.
- Burch G.E. Giles T.D. Colcolough H.L. Ischemic cardiomyopathy. Am Heart J 1970:79:291−292.
- Brigden W. Uncommon myocardial diseases. The non-coronary cardiomyopathies. Lancet 1957:2:1179−84.
- Brandenburg R.O. Chazov E. Cherian G. et al. Repon of the WHO/ISFC task force on definition and classification of cardiomyopathies. Circulation 198I:64:437A-8A.
- Felker G.M. Shaw L.K. O’Connor C.M. A standardized definition of ischemic cardiomyopathy for use in clinical research. J Am Coll Cardiol 2002:39:210−218.
- Atkinson J.B. Virmani R. Congestive heart failure due to coronary artery disease without myocardial infarction: clinicopathologic description of an unusual cardiomyopathy. Hum Pathol 1989−20:1155−62.
- Gheorghiade M., Bonow R.O. Chronic heart failure in the United States. A manifestation of coronaiy artery disease. Circulation 1998- 97: 282−9.
- Schwarz E.R., Schaper J., vom Dahl J., et al. Myocyte degeneration and cell death in hibernating human myocardium. J Am Coll Cardiol 1996−27:1577−85.
- Olivetti G. Abbi R. Quaini F., et al. Apoptosis in the failing human heart. N Engl J Med 1997−336:1131−41.
- Colucci W.S. Myocardial endothelin: does it play a role in myocardial failure? Circulation 1996:93:1069−72.
- Cohn JN. The management of chronic heart failure. N Engl J Med 1996−335:490−8.
- Bart B.A. Shaw L.K., McCants C.B. et al. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol 1997−30:1002−8.
- Follath F., Cleland J.G. Klein W. Murphy R. Etiology and response to drug treatment in heart failure. J Am Coll Cardiol 1998−32:1167−72.
- Uretsky B.F. Thygesen K. Armstrong P.W., et al. Acute coronary findings at autopsy in heart failure patients with sudden death: results from the Assessment of Treatment with Lisinopril And Survival (ATLAS) trial. Circulation 2000- 102:611−6.
- Wallis D.E. O’Connell J.B. Henkin R.E. Costanzo-Nordin M.R. Scanlon PJ. Segmental wall motion abnormalities in dilated cardiomyopathy: a common finding and good prognostic sign. J Am Coll Cardiol 1984:4:674−9.
- Rizzello V. Poldermans D. Biagini E" et al."Comparison of long-term effect of coronary artery bypass grafting in patients with ischemic cardiomyopathy with viable versus nonviable left ventricular myocardium" Am J Cardiol. 2004 Sep 15: 94(6):757−60.
- Bonow R.O. «Identification of viable myocardium» . Circulation. 1996. v94, nil. 2674−2680.
- Dilzian V. Bonow R.O." Current diagnostic techniques of assessing myocardial viability in hibernating and stunned myocardium." Circulation 1993: 87: 1−20.
- Rozanski .A. Berman D.S., Gray R. et al. «Preoperative prediction of reversible myocardial asynergy by post-exercise radionuclide ventriculography. N Engl J Med. 1982: 307- 212−216.
- Mock M.B. Ringqvist I. Fisher L.D. et al.» Survival of medically treated patients in coronary artery surgery study (CASS) registry." Circulation 1982: 66: 562−568.
- The SOLVD Investigators. «Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction» N Engl J Med- 1992- 327- 685−691.
- Jones R.H. Floyd R.D. Austin E.H., Sabiston D.C. Jr, 44 The role of radionuclide angioscintigraphy in the preoperative prediction of pain relief and prolonged survival following coronary artery bypass grafting" Ann Surg- 1983- 197- 743−754.
- Pryor D.B. Harrell F.E. Jr. Lee K.L. et al." Prognostic indicators from radionuclide angiography in medically treated patients with coronary artery disease." A.J.Cardiol: 1984−53:18−22.
- Lee K.L., Pryor D.B. Pieper K.S. et al «Prognostic value of radionuclide angiography in medically treated patients with coronary artery disease. A comparison with clinical and cateterization variables.» Circulation 1990−82:1705−1717.
- Taliercio C.P. Clements I.P. Zinsmeister A.R. Gibbons R.J. «Prognostic value and limitations of exercise radionuclide angiography in medically treated coronary artery disease» Mayo Clin Proc: 1988:63:573−582.
- Helfant R.H. Pine., Meister S.G. Feldman M.S. Trout R.G. Banka V.S. Nitroglycerin to unmask reversible asynergy: correlation with post coronary bypass ventriculography. Circulation. 1974−50:108−113.
- Chesebro J.H., Ritman E.L. Frye R.L. et al. Regional myocardial wall thickening response to nitroglycerin: a predictor of myocardial response to aortocoronary bypass surgery. Circulation. 1978−57:952−957.
- Bodenheimer M.M. Banka V.S., Hermann G.A. Trout R.G. Pasdar H., Helfant R.H. Reversible asynergy: histopathologic and electrographic correlations in patients with coronary artery disease. Circulation. 1976−53:792−796.
- Abrams J. Mechanisms of action of the organic nitrates in the treatment of myocardial ischemia. Am J Cardiol. 1992:70:30B-42B.
- Brown B.G., Bolson E. Petersen R.B. Pierce C.D. Dodge H.T. The mechanisms of nitroglycerin action: stenosis vasodilatation as a major component of the drug response. Circulation. 1981:64:1089−1097.
- Hisano K. Tomoike H. Inoue T. Mohri M. Nakamura M. lsosorbide dinitrate ameliorates myocardial ischemia after development of collateral function in a canine model. J Pharmacol Exp Ther. 1989−248:1289−1296.
- Fujita M. Yamanishi K. Hirai T. el al. Significance of collateral circulation in reversible left ventricular asynergy by nitroglycerin in patients with relatively recent myocardial infarction. Am Heart J. 1990−120:521−528.
- Aoki M. Sakai K. Koyanagi S. Takeshita A. Nakamura M. Effect of nitroglycerin on coronary collateral function during exercise evaluated by quantitative analysis of thallium-201 single photon emission computed tomography. Am Heart J. 1991:121:1361−1366.
- Rahimtoola S.H. The hibernating myocardium. Am Heart J. 1989:117:211−221.
- Brunken R. Schwaiger M. Grover-McKay M. Phelps M.E. Tillisch J. Schelbert H.R. Positron emission tomography detects tissue metabolic activity in myocardial segments with persistent thallium perfusion defects. J Am Coll Cardiol. 1987−10:557−567.
- Kiat H. Berman D.S. Maddahi J., et al. Late reversibility of tomographic myocardial thallium-201 defects: an accurate marker of myocardial viability. J Am Coll Cardiol. 1988:12:1456−1463.
- Dilsizian V., Rocco T.P. Freedman N.M. Leon M.B. Bonow R.O. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med. 1990−323:141−146.
- He Z.X. Darcourt J. Guignier A., et al. Nitrates improve detection of ischemic but viable myocardium by thallium-201 reinjection SPECT. J Nucl Med. 1993- 34: 1472−1477.
- Altehoefer C. Kaiser H-J. Dorr R. et al. Fluorine-18 deoxyglucose PET for the assessment of viable myocardium in perfusion defects in 99mTc-MIBI SPET: a comparative study in patients with coronary artery disease. Eur J Nucl Med. 1992−19:334−342.
- Udelson J.E., Coleman PS, Metherall J, et al. Predicting recovery of severe regional ventricular dysfunction: comparison of resting scintigraphy with 2<11T1 and «mTc-sestamibi. Circulation. 1994:89:25 522 561.
- Maurea S. Cuocolo A., Soricelli A., et al. Myocardial viability index in chronic coronary artery disease: technetium-99m-methoxy isobutyl isonitrile redistribution. J Nucl Med. 1995−36:1953−1960.
- Koplan BA., Beller G.A., Ruiz M., et al. Comparison between thallium-201 and technetium-99m-tetrofosmin uptake with sustained low flow and profound systolic dysfunction. J Nucl Med. 1996−37:1398−1402.
- Bisi G., Sciagra R., Santoro G.M., Zerauschek F., Fazzini P.F. Sublingual isosorbide dinitrate to improve Tc-99m-teboroxime perfusion defect reversibility. J Nucl Med. 1994−35:1274−1278.
- Flotats A. Carrio I., Estorch M., et al. Nitrate administration to enhance the detection of myocardial viability by technetium-99m tetrofosmin single photon emission tomography. Eur J Nucl Med 1997−24:767−73.
- Abrams J. Mechanisms of action of the organic nitrates in the treatment of myocardial ischemia. Am J Cardiol 1992−70:30B-42B.
- Tadamura E. Mamede M., Kubo S., et al. The effect of nitroglycerin on myocardial blood flow in various segments characterized by rest-redistribution thallium SPECT. J Nucl Med 2003:44:745−51.
- Gregg D.E. Effect of coronary perfusion pressure or coronary flow on oxygen usage of the myocardium. Circ Res 1963:13:497−500.
- Mansoor M.R. Heller G.V. Gated SPECT imaging. Semin Nucl Med 1999:29:271−8.
- Smanio E.P.Watson D.D. Segalla D.L., Vinson E.L., Smith W.H., Beller G.A. Value of gating of technetium-99m sestamibi single-photon emission computed tomographic imaging. J Am Coll Cardiol 1997−30:1687−92.
- Maruyama A. Hasegawa S. Paul A. K et al. „Myocardial viability assessment with gated SPECT Tc-99m tetrofosmin % wall thickening: Comparison with F-18 FDG-PET“ Annals of Nuclear Medicine Vol. 16, No. 1,25−32,2002.
- Ziffer J.A., Cooke C.D. Folks R.D. LaPidus A.S., Alazraki N.P., Garcia E.V. Quantitative myocardial thickening assessed with sestamibi: clinical evaluation of a count-based method, abstract. J Nucl Med 1991: 32: 1006.
- Williams K.A., Taillon L.A. Reversible ischemia in severe stress technetium99m-labeled sestamibi perfusion defects assessed from gated single-photon emission computed tomographic polar map Fourier analysis. J Nucl Cardiol 1995: 2: 199−206.
- Tischler M.D. Niggel J.B. Battle R.W. Fairbank J.T. Brown K.A. Validation of global and segmental left ventricular contractile function using gated planar technetium-99msestamibi myocardial perfusion imaging. J Am Coll Cardiol 1994: 23: 141−145.
- Gunning M.G. Anagnostopoulos C. Davies G. Forbat S.M. Ell P.J. Underwood S.R. Gated technetium-99m-tetrofosmin SPECT and cine MRI to assess left ventricular contraction. J Nucl Med 1997: 38: 438−442.
- Maruyama A. Hasegawa S. Paul A. Kr., et al."Myocardial viability assessment with gated SPECT Tc-99m tetrofosmin % wall thickening: Comparison with F-18 FDG-PET» Annals of Nuclear Medicine 2002- Vol. 16. No. 1,25−3.
- Altehoefer C., Vom Dahl J. Biedermann M. Uebis R. Beilin 1. Sheehan F. et al. Significance of defect severity in technetium- 99m-MIBI SPECT at rest to assess myocardial viability: comparison with fluorine-18-FDG PET. J Nucl Med 1994- 35: 569−574.
- Bodenheimer M.M. Banka V.S., Hermann G.A. Trout R.G. Pasdar H. Helfant R.H. Reversible asynergy. Histopathologic and electrographic correlations in patients with coronary artery disease. Circulation 1976: 53: 792−796.
- Hoffman E.J. Huang S.C. Phelps M.E. Quantitation in positron emission computed tomography: I. Effect of object size. J Comput Assist Tomogr 1979- 3: 299−308.
- Fukuchi K. Uehara T. Morozumi T" Tsujimura E., Hasegawa S., Yutani K. et al. Quantification of systolic count increase in technetium-99m-MIBI gated myocardial SPECT. J Nucl Med 1997: 38: 1067−1073.
- Sorenson J.A. Phelps M.E. Physics in Nuclear Medicine. Philadelphia- WB Saunders, 1987.
- Rizzello V. Schinkel A.F. Bax J.J. et al. «Individual prediction of functional recovery after coronary revascularization in patients with ischemic cardiomyopathy: the scar-to-biphasic model» Am J Cardiol. 2003 Jun 15−91(12): 1406−9.
- Parisi A.F. Folland E.D. Hartigan P. «A comparison of angioplasty with medical Theipy in the treatment of single-vessel coronary disease. Veteran Affairs ACME investigators» N Engl. J. Med. 1992:326:10−16.
- Goy J.J. Eeckhout E., Burnand B. Et al. «Coronary angioplasty versus left internal mammary artery grafting for isolated proximal left anterior descending artery stenosis» Lancet. 1994:343:1449−1453.
- King S.B. III. Lembo N.J., Weintraub W.S. «A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST)» N Engl. J. Med. 1994:331:1044−1050.
- The BAR1 protocol. Protocol for the Bypass Angioplasty Revascularization Investigation. Circulation 1991:84(suppl V). V-l-27.
- Mark D.B. Gardner L.H., Nelson C.L. et al «Long-term costs of therapy for CAD: a prospective comparison of coronary angioplasty? Coronary bypass surgery and medical therapy in 2258 patients» Circulation: 88 suppl D: I-480.
- Berger P.B. Velianou J.L. Vlachos H.A. Feit F. Jacobs A.K. Faxon D.P. Attubato M. Keller N. Stadius M.L. Werner B.H. Williams D.O.
- Detre K.M. Survival following coronary angioplasty versus coronary artery bypass surgery in anatomic subsets in which coronary artery bypass surgery improves survival compared with medical therapy. J Am Coll Cardiol 2001:38:1440−9.
- Moses et al. Rapamycin (sirolimus) eluting stent for prevention of in-stent restenosis. SIR1US. N Engl J Med 2003: 349: 1315−1323.
- Morice et al. Rapamycin (sirolimus) eluting stent for prevention of in-stent restenosis. RAVEL. N Engl J Med 2002- 346: 1773−1780.
- Marsico F. Morenghi E. Parenti D.Z. Milone F. Maiello L. Carcagni A. Scatturin M. Presbitero P. Ital Heart J. Immediate and late results of coronary angioplasty in patients with severe left ventricular dysfunction. 2003 Dec-4(12):838−42.
- Di Sciascio G. Patti G., D’Ambrosio A., Nusca A. Catheter Cardiovasc Interv. Coronary stenting in patients with depressed left ventricular function: acute and long-term results in a selected population. 2003 Aug-59(4):429−33.
- Morrison D.A., Sethi G., Sacks J. et al., A multicenter, randomized trial of percutaneous coronary intervention versus bypass surgery in high-risk unstable angina patients. Control Clin Trials 1999:20. pp. 601−619.
- Panithaya Chareonthaitawee. Bernard J. Gersh, Philip A. Araoz and Raymond J. Gibbons. Revascularization in Severe Left Ventricular Dysfunction: The Role of Viability Testing. J. Am. Coll. Cardiol. 2005−46−567−574.
- Grossman W. Diastolic dysfunction in congestive heart failure. New Engl J Med 1991- 325: 1557−64.
- Alderman E.L., Bourassa M.G. Cohen L.S. et al. Ten-year follow-up of survival and myocardial infarction in the randomized coronary artery surgery study. Circulation 1990- 82: 1629−46.
- Pasquet A., Robert A., D’Hondt A.M. Dion R., Melin J.A., Vanoverschelde J.L. Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular ischemic dysfunction. Circulation 1999:100:141−8.
- Pagley P.R. Beller G.A. Watson D.D. Gimple L.W. Ragosta M. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation 1997−96:793−800.
- Tamaki N. Kawamoto M. Takahashi N. et al. Prognostic value of an increase in fluorine-18 deoxyglucose uptake in patients with myocardial infarction: comparison with stress thallium imaging. J Am Coll Cardiol 1993: 22:1621−7.124.
- Grovera F.L. Barrb M.L. Edwardsc L.B. et all. «Thoracic transplantation» American Journal of Transplantation 2003- 3 (Suppl. 4): 91−102.
- Simes P.A. Golf S., Myreng Y., et al. Stenting in Chronic Coronary Occlusion (S1CCO): a randomized controlled trial of adding stent implantation after succesful angioplasty. J Am Coll Cardiol 1996: 28: 1441−51.
- R. Sciagra. M. Leoncini. Gated single-photon emission computed tomography. The present-day «one-stop-shop» for cardiac imaging. The quarterly journal of nuclear medicine 2005: 49:19−29.